China Universal Asset Management Co. Ltd. Has $15.25 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN

China Universal Asset Management Co. Ltd. reduced its stake in Regeneron Pharmaceuticals (REGN) by 7.5% in the fourth quarter, now holding 19,753 shares valued at $15.25 million, making it their 19th largest holding. Despite this reduction and recent insider selling, Regeneron Pharmaceuticals has several positive catalysts, including FDA approval of gene therapy Otarmeni, tariff relief, and a dividend increase, contributing to a consensus “Moderate Buy” rating from analysts. The company also recently reported an earnings beat, with reported EPS of $11.44 exceeding the consensus estimate of $10.74.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin